MapLight Therapeutics (MPLT)
Develops circuit-selected medicines for central nervous system disorders through a clinical-stage pipeline.
$13.06
Pre-market0.00 (0.00%)
At close$13.06(−1.88%)
Something off on this page? Send us feedback.
Next report
Sep 18, 2026
estimated · in 15 days
EPS estimate
−$1.35
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
————Dec '25May '26Aug '26Sep '26
Reported————−$37.18−$1.34−$1.32Pending
Estimate————−$1.72−$0.96−$1.35−$1.35
Surprise————−2,061.6%−39.3%+2.2%—
RevenueReportedEstimate
————Dec '25May '26Aug '26Sep '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | −$1.35 | — | — |
| Aug 2026 | −$1.35 | −$1.32 | +2.2% |
| Jun 2026 | −$1.06 | — | — |
| May 2026 | −$0.96 | −$1.34 | −39.3% |
| Dec 2025 | −$1.72 | −$37.18 | −2,061.6% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | −$1.35 | — | — | — | — | — | — |
| Aug 13, 2026 | −$1.35 | −$1.32 | +2.2% | — | — | — | +1.5% |
| Jun 25, 2026 | −$1.06 | — | — | — | — | — | — |
| May 14, 2026 | −$0.96 | −$1.34 | −39.3% | — | — | — | −1.9% |
| Dec 4, 2025 | −$1.72 | −$37.18 | −2,061.6% | — | — | — | +0.8% |